Chronic Hand Eczema.
Weisshaar E.
Am J Clin Dermatol. 2024 Nov;25(6):909-926. doi: 10.1007/s40257-024-00890-z. Epub 2024 Sep 19.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators.
JAMA Dermatol. 2025 Feb 1;161(2):147-156. doi: 10.1001/jamadermatol.2024.4796.
European S2k Guideline on Chronic Pruritus.
Weisshaar E, Müller S, Szepietowski JC, Dalgard F, Garcovich S, Kupfer J, Gimenez-Arnau A, Lambert J, Mettang T, Misery L, Savk E, Tschachler E, Wallengren J, Ständer S.
Acta Derm Venereol. 2025 Aug 22;105:adv44220. doi: 10.2340/actadv.v105.44220.
S2k guideline: Diagnosis and treatment of chronic pruritus.
Ständer S, Zeidler C, Augustin M, Darsow U, Kremer AE, Legat FJ, Koschmieder S, Kupfer J, Mettang T, Metz M, Nast A, Raap U, Schneider G, Ständer H, Streit M, Schut C, Weisshaar E.
J Dtsch Dermatol Ges. 2022 Oct;20(10):1387-1402. doi: 10.1111/ddg.14830.
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.
Legat FJ, Kwatra SG, Reich A, Boulinguez S, Tsianakas A, Sauder M, Barbarot S, Szepietowski JC, Conrad C, Pink AE, Weisshaar E, Misery L, Metz M, Laquer VT, Sivamani RK, Yosipovitch G, Thaçi D, Skov L, Chen X, Noda A, Jabbar-Lopez ZK, Piketty C, Ständer S.
J Eur Acad Dermatol Venereol. 2025 Dec 17. doi: 10.1111/jdv.70266. Online ahead of print.
Prevalence of prurigo nodularis in Sweden.
Antelmi A, Metsini A, Regnell SE, Carlberg M, Svensson Å, von Kobyletzki L.
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e904-e906. doi: 10.1111/jdv.19986. Epub 2024 Mar 29.
Polymorphic Light Eruption.
Sathe NC, Ramsey ML.
2026 Feb 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Position Statement: Linear prurigo is a subtype of chronic prurigo.
Pereira MP, Zeidler C, Nau T, Bobko S, Evers AWM, Garcovich S, Gonçalo M, Halvorsen JA, Lambert J, Legat FJ, Leslie T, Metz M, Misery L, Nordlind K, Reich A, Schneider G, Ständer H, Streit M, Szepietowski JC, Wallengren J, Weisshaar E, Ständer S; EADV Task Force Pruritus.
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):263-266. doi: 10.1111/jdv.15275. Epub 2018 Oct 31.
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
Ständer S, Pereira MP, Zeidler C, Legat FJ, Misery L, Lönndahl L, Bewley AP, Brenaut E, Bobko S, Elberling J, Evers AWM, Garcovich S, Gieler U, Gonçalo M, Kupfer J, Lambert J, Lvov A, Metz M, Michenko A, Papadavid E, Reich A, Savk E, Schneider G, Schut C, Serra-Baldrich E, Ständer HF, Szepietowski JC, Wallengren J, Weisshaar E, Augustin M.
J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1687-1693. doi: 10.1111/jdv.20102. Epub 2024 May 13.
Occupational contact allergy to nifuroxazide simulating prurigo nodularis.
Kieć-Swierczyńska M, Krecisz B.
Contact Dermatitis. 1998 Aug;39(2):93-4. doi: 10.1111/j.1600-0536.1998.tb05849.x.
